论文部分内容阅读
心包切开术后综合征(postpericardiotomy syndrome,PPS)是一种炎性胸膜心包综合征,发病因素包括自身免疫、特殊病毒、潜伏病毒感染再发作等.PPS具有自限性,但可以长期迁延.发生PPS的患者,住院时间显著延长,再入院率升高,有创介入性操作增加.PPS的治疗主要是基于经验应用抗炎药物.临床研究显示单药应用秋水仙碱具有预防术后PPS的作用,但并不能降低术后心房颤动、心包积液以及胸腔积液的发生率.本文主要分析PPS的发病率、高危因素、临床特征、诊治标准、预防措施以及预后.“,”The postpericardiotomy syndrome (PPS) is an inflammation of the pericardium or pleura following a variety of pericardial injuries.The potential pathogenic factors of the PPS are autoimmune,special virus and latent virus infection.PPS is self-limited,but may lead to prolonged hospital stay,readmissions,and need for invasive interventions.The therapy for PSS is mainly empiric anti-inflammatory therapy.The perioperative use of colchicine could reduce the incidence of PPS but is not effective for postoperative atrial fibrillation or postoperative pericardial/pleural effusion.This article mainly analyzes the incidence,risk factors,clinical features,diagnosis and treatment standards,preventive measures and prognosis of PPS.